ABSTRACT: Polyadenylation is a process of endonucleolytic cleavage of the mRNA, followed by addition of up to 250 adenosine residues to the 3 end of the mRNA. Polyadenylation is essential for eukaryotic mRNA expression, and CstF-64 is a subunit of the CstF polyadenylation factor that is required for accurate polyadenylation. We discovered that there are two forms of the CstF-64 protein in mammalian male germ cells, one of which (CstF-64) is expressed in all tissues, the other of which (CstF-64) is expressed only in male germ cells and in brain (albeit at significantly lower levels in the brain). Therefore, we were surprised to find that, using reverse transcription-PCR, cDNA cloning, and RNA blot analyses, CstF-64 mRNA was expressed at higher levels in brain than in testis. Also, CstF-64 mRNA was expressed at lower but detectable levels in all tissues tested, including epididymis, heart, kidney, liver, lung, muscle, ovary, spleen, thymus, and uterus. These results suggest the hypothesis that CstF-64 mRNA is regulated at the translational or post-translational level.
INTRODUCTION
Eukaryotic mRNA transcription is a complex stepwise process that involves transcriptional initiation, elongation, and termination. 1, 2 Coordinately with transcription, the nascent mRNA is capped at its 5′ end, introns are removed by splicing, and its 3′ end is cleaved and polyadenylation occurs. 3 Polyadenylation is the process of endonucleolytic cleavage of the mRNA at a specific site followed by addition of up to 250 adenosine residues to the newly formed 3′ end. Accurate and efficient polyadenylation is essential for gene expression and is an important controller of translation and mRNA stability. The polyadenylation mechanism involves four steps: recognition of the correct site of cleavage/polyadenylation, endonucleolytic cleavage of the pre-mRNA at that site, addition of poly(A) to the newly formed 3′ end, and degradation of the remaining downstream portion of the pre-mRNA transcript.
Several factors are required for polyadenylation. Two of these, the cleavage and polyadenylation specificity factor (CPSF), with four polypeptide subunits, and the cleavage stimulation factor (CstF), with three subunits, are important for the recognition and cleavage steps. [4] [5] [6] Over many years, CstF has been implicated in regulation of pre-mRNA polyadenylation in several systems. In particular, RNA binding of the 64,000 M r subunit of CstF, CstF-64 (gene name, Cstf2) has been shown to regulate 7 or to correlate with [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] polyadenylation efficiency of specific substrates. Other studies showed that CstF-64 binds to a U-or GU-rich sequence downstream of most eukaryotic polyadenylation signals. 9, 10, 21, 22 Furthermore, CstF-64 was shown to be essential for vertebrate 23 and invertebrate 24 viability. Together, these data suggest that CstF-64 is a key regulatory component of the polyadenylation machinery in most, if not all, eukaryotic cells.
Male germ cells express a second form of CstF-64 called τCstF-64. The τCstF-64 protein is expressed predominantly in meiotic and postmeiotic male germ cells 25 and to a smaller degree in brain, spleen, and thymus; 25, 26 in rats, τCstF-64 is also expressed in the liver. 26 While CstF-64 is X-linked, τCstF-64 is encoded by a different gene, Cstf2t, which is on chromosome 19 in mice 27 and chromosome 10 in humans. 28 We have hypothesized that τCstF-64 is expressed in male germ cells, because Cstf2 is on the X chromosome and is therefore inactivated during male meiosis. 29, 30 This leads to the necessity of an auxiliary copy of Cstf2 that can be expressed during meiosis, in a manner similar to that described for phosphoglycerokinase (Pgk1, Pgk2), pyruvate dehydrogenase E1a subunit (Pdha1, Pdha2), centrin (Cetn2, Cetn1), heterogeneous ribonucleoprotein G (HNRNPG, HNRNPG-T), Utp14a and Utp14b (Utp14a, Utp14b), and others. 30, 31 This places τCstF-64 in a class of retroposons that are involved in male germ cell-specific development and X chromosome inactivation. Although the τCstF-64 protein is expressed at high levels in testis and at lower levels in brain, spleen, and thymus, we were surprised to find that expression of the τCstF-64 mRNA was more widespread. Reverse transcription-PCR (RT-PCR)-based cloning experiments revealed that the τCstF-64 mRNA could be cloned from a wide variety of tissues (including whole blood, liver, and muscle) from both males and females from a variety of eutherians (B. Dass, unpublished) (TABLES 1 and 2). Therefore, using RNA blotting and quantitative RT-PCR (qRT-PCR), we examined τCstF-64 mRNA levels in several tissues from mice and rats. Much to our surprise, significant levels of τCstF-64 mRNA were detected in every tissue examined, although τCstF-64 protein has only been reported in a few tissues. Therefore, we propose that the majority of the regulation of τCstF-64 expression is translational or post-translational. If translational, there must exist translational control elements in the τCstF-64 mRNA, possibly in its 3′-untranslated region.
MATERIALS AND METHODS

Animals Used in This Study
In all studies, animal protocols were approved by the Institutional Animal Care and Use Committee and National Institutes of Health guidelines for animal care were followed. Adult CD-1 mice were anesthetized with CO 2 and killed by cervical dislocation before tissue collection.
Antibodies and Protein Immunoblot Assays
Testicular tubules were prepared by decapsulating freshly harvested mouse testes in phosphate-buffered saline and washing to remove interstitial cells. Nuclei were prepared by centrifugation over a sucrose pad, boiled and sonicated in loading buffer, separated by 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, and transferred to polyvinylidene difluoride membranes for immunoblotting. 25 Membranes were stained with Ponceau S and incubated 1 to 16 hours in block solution (Tris-buffered saline with 10% nonfat dry milk). Monoclonal antibodies 3A7 and 6A9 were prepared against the human CstF-64 but specifically recognize the somatic CstF-64 and τCstF-64 protein isoforms, respectively, in mice. [25] [26] [27] Antibodies were used at a dilution of 1:50. Membranes were incubated with primary antibody in block followed by incubation with horseradish peroxidase-coupled sheep anti-mouse immunoglobulin G (1:10,000). After washing in Tris-buffered saline, immunoreactive bands were visualized by chemiluminescence using the Pierce SuperSignal™ kit (Pierce Biotechnology, Inc., Rockford, IL).
RNA Blot ("Northern") Analysis
Tissues were collected from adult male CD-1 mice (Charles River Laboratories, Wilmington, MA), frozen in liquid nitrogen, and stored at −80°C. Alternatively, tissues were collected into RNAlater® (Ambion, Inc., Austin, TX) and stored at 4°C. Total RNA was prepared from frozen tissues using TRIzol (Invitrogen Corporation, Carlsbad, CA) according to the manufacturer's directions. RNA integrity was estimated by examination of mobilities of 18S and 28S rRNA after ethidium bromide staining of formaldehyde gels. 32 RNA blots were prepared as described previously, 33 except that transfer to nylon membranes was by capillary blotting overnight in 10 × SSC (standard saline citrate). For probe, DNA was isolated from a gel-purified 850-bp EcoRI fragment representing the 5′ end of the mouse τCstF-64 cDNA. 27 [ 32 P]dCTP-labeled probes were prepared by random priming using the Prime-It® II kit (Stratagene, La Jolla, CA). Prehybridization and hybridization were at 55°C in hybridization solution (5 × SSC, 50% formamide, 12.5 mM sodium phosphate, pH 6.6, 0.1% SDS, 0.2 mg/ml sonicated salmon sperm DNA, 0.4 mg/ml yeast tRNA). After 16 to 24 hours of hybridization, filters were washed four times at room temperature in 1 × SSC, 0.1% SDS and two to three times in 0.1 × SSC, 0.1% SDS at 65°C, followed by autoradiography with an intensifying screen at −80°C.
RT-PCR and qRT-PCR
Total RNA was isolated from mouse tissues using the TRIzol reagent, and cDNA was made using SuperScript™ II reverse transcriptase according to the manufacturer's recommendations (Invitrogen Corporation, Carlsbad, CA). Conditions for qRT-PCR (or "real-time" qRT-PCR) using the LightCycler® II apparatus (Roche Diagnostics Corporation, Indianapolis, IN) were optimized empirically for each primer set, and the number of cycles was confirmed to be within the linear range. 34 Using qRT-PCR, we amplified the mRNAs for Cstf2t and the ribosomal protein S16 as a control. The primers and PCR conditions were as follows: Cstf2t forward primer, 5′-GCAAAGCCAGGTAACTCCACAA-3′, and reverse primer, 5′-CCTGCATCTTC-CTCACCTTAC-3′; expected product, 446 bp; MgCl 2 buffer, 4 mM; Roche Light Cycler settings of denaturing at 94°C for 30 seconds, annealing at 59°C for 0 seconds, and elongation at 72°C for 20 seconds; all slopes at 20. Also used was the following: S16 forward primer, 5′-CGCTGCAGTCCGTGCAGGTCTT-3′, and reverse primer, 5′-TCCAAACTTTTTGGATTCGCAGCG-3′; expected product, 383 bp; MgCl 2 buffer, 3 mM; Roche Light Cycler settings of denaturing at 94°C for 0 seconds, annealing at 60°C for 5 seconds, and elongation at 72°C for 20 seconds; all slopes at 20. All experiments were performed at least three times using RNA from different animals. The data in FIGURE 3 are normalized from averages of the raw gene-specific data divided by the averages of S16 data for each tissue.
RESULTS
CstF-64 Protein Is Expressed in Many Mouse Tissues
The CstF-64 polyadenylation protein was expressed in all tissues examined. 25, 26 Previously, we described a variant form of the CstF-64 polyadenylation protein that was expressed only in mouse testis and brain 25 and, oddly, in rat liver. 26 We named this protein τCstF-64. 27 FIGURE 1 shows the tissue distribution of CstF-64 and τC stF-64 in mouse tissues. The CstF-64 isoform was expressed in HeLa cells (panel A, lane 1) and in all mouse tissues examined (lanes 2-8) . The τCstF-64 isoform was expressed at low levels in brain (panel B, lane 2) and at higher levels in testis (lane 7). τCstF-64 was undetectable in any other mouse tissues in this experiment (lanes 3-6 25 Reproduced by permission.) and 8). This suggests that the CstF-64 polyadenylation protein functions in all tissues, but that the τCstF-64 protein only functions appreciably in testis and in brain.
CstF-64 mRNA Is Expressed in Many Mouse Tissues
In attempting to clone the cDNA encoding τCstF-64 from several different animal species (B. Dass, unpublished), we noticed that the mRNA for τCstF-64 was present in several tissues beyond testis and brain and in animals of both sexes (TABLES 1 and 2). TABLE 1 lists the species in which the τCstF-64 cDNA was cloned from RNA from testis or germ cell tissues, consistent with the high levels of expression of the τCstF-64 protein in testis. However, as shown in TABLE 2, the τCstF-64 cDNA was also found in nontesticular tissues and from animals of both genders where the τCstF-64 protein was not expressed. This suggested that the τCstF-64 mRNA might be expressed in a greater range of tissues than was the protein. On the basis of these and other similar results, we decided to examine the distribution of the τCstF-64 mRNA in multiple mouse tissues Whole-cell RNA from mouse tissues was prepared, separated by denaturing 1.2% agarose gel electrophoresis, blotted to nylon membranes, and hybridized with probes representing the N-terminal RNA-binding domain and adjacent regions of τCstF-64 (FIG. 2A) . For comparison of loading, the separated RNA was stained with ethidium bromide and photographed (FIG. 2B) . In every tissue examined in both mice (FIG.  2A) and rats (not shown), some τCstF-64-hybridizing RNA (about 4.5 kb; arrow) was detected (FIG. 2A, lanes 1-8) . Testis RNA (where τCstF-64 protein expression was reported to be greatest 25, 26 ) showed the greatest intensity of signal, although some of the variation in signal may have been due to uneven probe hybridization (e.g., lane 7). However, RNA from other tissues such as brain (where τCstF-64 is also expressed, although at levels lower than in testis), thymus, heart, spleen, and kidney (where τCstF-64 protein expression was low or unmeasurable 26 ) also showed visible intensity of τCstF-64-hybridizing signal. In contrast, an earlier report showed that CstF-64 mRNA was at exceedingly low levels in all tissues except testis. 33 
CstF-64 mRNA Levels Are Highest in Brain and Testis
But Are Detectable in All Tissues Examined
Because we could detect τCstF-64 mRNA in several mouse tissues by RNA blotting, including several that have not been shown to express τCstF-64 protein, we decided to examine τCstF-64 mRNA levels more accurately using qRT-PCR. 34 RNAs , unpublished) , cDNAs representing τCstF-64 were cloned from RNA from the indicated tissues from each of the indicated species.
from the indicated tissues were isolated from adult male CD-1 mice, except for ovary and uterus, which were from adult CD-1 female mice. For comparison, we also included RNA from testes of mice in which the entire coding region of the τCstF-64 gene, Cstf2t, had been deleted by targeted disruption (B. Dass et al., unpublished) . Note that Cst2t mRNA is undetectable in testes of knockout mice (FIG. 3) .
The τCstF-64 mRNA amount is greater in brain RNA (FIG. 3, 0 .00325 copies/ copy of S16 mRNA) than in testis (0.00236 copies/copy of S16). This does not reflect protein expression, since τCstF-64 expression is much greater in testis than in brain. 25, 26 Next in rank is heart, in which τCstF-64 mRNA is approximately 26% of that in brain (0.00085 copies/copy of S16). Other amounts vary from 0.0005 (epididymis) to 0.0001 (lung) copies/copy of S16. Again, note that these amounts are not reflective of protein expression, since we have reported low but detectable τCstF-64 protein in spleen and thymus, 26 but not in the other tissues assayed here.
DISCUSSION
It is well-established that the τCstF-64 protein is expressed in a highly restricted set of tissues, primarily testis and brain. 25, 26 However, we show here that the mRNA encoding τCstF-64 is not so highly restricted. We found the highest levels of τCstF-64 mRNA in brain and testis (in which the τCstF-64 protein is found). However, we also found moderate levels of τCstF-64 mRNA in some tissues (heart, skeletal muscle, kidney, and epididymis) and lower levels in several other tissues (liver, lung, ovary, spleen, thymus, and uterus). None of these tissues has measurable levels of τCstF-64 protein in mice, though liver, spleen, and thymus express τCstF-64 protein in rats. Because the protein expression levels do not correlate with the mRNA levels, we propose that expression of the τCstF-64 protein is controlled by a translational element, the mechanism for which we have not discovered.
Messenger RNA processing is an essential set of steps in eukaryotic gene expression. In addition to being required for assembly of exons within the mature mRNA, the machineries for capping, splicing, and polyadenylation are all required for efficient transcription. 1, 2, 35 Alternative mRNA processing is also essential to ensure the diversity of mRNA processing required for eukaryotic development and physiology. Two tissues with the highest degree of alternative mRNA processing are brain and testis. [36] [37] [38] [39] While it is obvious there is a need for diversity of gene expression in the brain, 40 it is less obvious why such diversity is required for testicular germ cell function. 37, 38 It has been speculated that diversity of gene expression in male germ cells is to provide functions of genetic diversity through translational control mechanisms, 41 but there are few data to support these and similar theories. We speculate, however, that alternative members of core proteins involved in gene expression, such as τCstF-64, are key contributors to genetic diversity in these two tissues.
Why, then, is τCstF-64 mRNA expressed in such a wide range of tissues if the protein is not? Why is τCstF-64 mRNA higher in brain than testis, though the protein expression is weighed heavily in the opposite direction? We are not certain of the answers to these questions, and we may not be able to answer them until the mechanism of translational or post-translational control is uncovered. One possibility is that the promiscuous expression of τCstF-64 mRNA is a consequence of its history as an expressed retroposon. 28 It has been speculated that retroposon expression in the testis is increased because of general mechanisms that increase transcription from heterochromatic DNA. 31, 42 However, this would suggest that many retroposed genes would behave similarly, which has not been reported. A second possibility is that τCstF-64 mRNA is promiscuously expressed because it is located inside an intron of another gene, Prkg1, a type I cGMP-dependent protein kinase. 43 Because Prkg1 has a wide range of expression, Cstf2t is likely in a euchromatic region of the chromosome and may be expressed widely. There are two arguments that temper this possibility, however: first, another retroposed gene with germ cell expression, Utp14b, is within the intron of a gene, Facl3, but does not show a similar wide range of expression. 44 Second, targeted disruption of Cstf2t by replacement with a gene encoding resistance to G418 does not alter Prkg1 expression, suggesting that Cstf2t and Prkg1 are transcriptionally independent (B. Dass, unpublished data). Furthermore, none of these speculations addresses the likely translational or post-translational mechanism that must repress τCstF-64 expression in all but a few tissues. It seems unlikely we will be able to answer these questions satisfactorily until we have investigated more closely the mechanism of τCstF-64's transcriptional and translational control.
